Latanoprost Solution
Product Images NDC 64980-516

8 FDA label images from Rising Pharma Holdings, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Latanoprost (NDC 64980-516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (3e39cb42 Ea34 43c9 90e5 Bf9a0961c0b5 01)

Structure (3e39cb42 Ea34 43c9 90e5 Bf9a0961c0b5 01)
Chemical structure diagram of latanoprost showing its molecular formula representation and molecular weight (432.58). This represents the active ingredient in the product LATANOPROST, 50 mcg/mL ophthalmic solution by Rising Pharma Holdings, Inc.*
FDA Label Image

Figure A (3e39cb42 Ea34 43c9 90e5 Bf9a0961c0b5 02)

Figure A (3e39cb42 Ea34 43c9 90e5 Bf9a0961c0b5 02)
LATANOPROST 50 micrograms/mL ophthalmic solution in a small, clear plastic bottle with a green dropper cap. The bottle includes a barcode and a white label with printed text. The product is labeled under Rising Pharma Holdings, Inc.*
FDA Label Image

Figure B (3e39cb42 Ea34 43c9 90e5 Bf9a0961c0b5 03)

Figure B (3e39cb42 Ea34 43c9 90e5 Bf9a0961c0b5 03)
An instructional image showing hands holding a small ophthalmic solution bottle, demonstrating how to remove or adjust a green cap with a ribbed grip. A black arrow points to the cap, indicating the direction of movement or removal. The bottle appears to be labeled but text is not clearly visible.*
FDA Label Image

Figure C (3e39cb42 Ea34 43c9 90e5 Bf9a0961c0b5 04)

Figure C (3e39cb42 Ea34 43c9 90e5 Bf9a0961c0b5 04)
An instructional illustration showing a hand removing the child-resistant cap from a small ophthalmic solution bottle, likely demonstrating how to open a latanoprost eye drop container.*
FDA Label Image

Figure D (3e39cb42 Ea34 43c9 90e5 Bf9a0961c0b5 05)

Figure D (3e39cb42 Ea34 43c9 90e5 Bf9a0961c0b5 05)
An instructional image depicting proper use of an ophthalmic solution bottle of LATANOPROST 50 ug/mL. The image shows a hand holding the small, white plastic bottle with a green, pointed dispensing tip, indicating how to squeeze the bottle to administer the eye drops.*
FDA Label Image

Figure E (3e39cb42 Ea34 43c9 90e5 Bf9a0961c0b5 06)

Figure E (3e39cb42 Ea34 43c9 90e5 Bf9a0961c0b5 06)
Illustration shows a person administering LATANOPROST 50 mcg/mL ophthalmic solution by tilting their head back and applying a drop into the eye from the bottle. The hand holds the bottle upside down near the eye to demonstrate eye drop instillation technique.*
FDA Label Image

Figure F (3e39cb42 Ea34 43c9 90e5 Bf9a0961c0b5 07)

Figure F (3e39cb42 Ea34 43c9 90e5 Bf9a0961c0b5 07)
An instructional image showing a hand holding a small ophthalmic solution bottle labeled LATANOPROST 50 ug/mL. A finger is placed on the cap with an arrow indicating the direction to twist or remove the cap for opening.*
FDA Label Image

Carton (3e39cb42 Ea34 43c9 90e5 Bf9a0961c0b5 08)

Carton (3e39cb42 Ea34 43c9 90e5 Bf9a0961c0b5 08)
Latanoprost Ophthalmic Solution 0.005% (50 mcg/mL) in a 2.5 mL bottle by Rising Pharma Holdings, Inc. The label shows the solution strength as 125 mcg/2.5 mL, specifying sterile ophthalmic use for the eyes only. It includes detailed usage instructions, storage conditions, inactive ingredients, and manufacturer and distributor information. The packaging also has barcodes and a caution that it is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.